Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
BSN 315
sherpath
| Question | Answer |
|---|---|
| A patient with a history of numbness, weakness, and blurred vision recently was diagnosed with multiple sclerosis. which statement describes the underlying pathophysiology for these symptoms? | inflammation and myelindestruction in the CNS |
| The nurse is caring for a patient hospitalized with an acute episode of MS. The nurse anticipates administering which medication first? | Methyprednisolone IM |
| The nurse administers a new drug to a patient who has been dianosed with a psychiatric disorder. The nurse explains that the drug may take several weeks before full therapeutic effects are seen. Which drug did the nurse administer? | An antidepressant |
| Natalizumab is a very effective agent for treating mutiple sclerosis. Which problem is associcated with the administration of this drug that makes it a second line agent? | rare cases of dangerous brain infections |
| The nurse is reviewing the care of patients with alzheimer disease. which factor is associated with the pathophysiology of this disease? | acetylcholine |
| The nurse is reviewing the care of patients with Alzheimer's disease (AD). Which factors are associated with the pathophysiology of this disease? Select all that apply. | Beta-amyloid and neuritic plaques, Neurofibrillary tangles and tau & neuronal degeneration and decreased acetylcholine |
| Which inhibitory neurotransmitter is involved in parkinson disease? | dopamine |
| Which main anatomic area of the brain is affected in a patient with parkinson disease? | substantia nigra |
| Which compound serves as an opioid peptide transmitter? | endorphins enkephalins |
| which patient should be evaluated for potential toxic effects of antiepileptic therapy? | patient with carbamazepine level of 15 mcg/mL |
| which nursing action is appropriate for a patient in convulsive status epilepticus? | administer intravenous antiepileptic drug therapy |
| which neurotransmitter level is decreased by as much as 90% in patients with severe alzheimer disease? | acetylcholine |
| Which information stated by a student about central nervous system (CNS) neurotransmitters will cause the nursing instructor to follow up? | we have three major neurotransmitters that are released in the CNS |
| which report by a patient taking fingolimod requires prompt evaluation by the prescriber? | dizziness and fatigue |
| Which nursing intervention is appropriate when administering phenytoin via intravenous route? | administer the medication no faster than 50 mg/min |
| which drug used in the treatment of alzheimer disease blocks neuronal receptors for n-methyl-d-aspartate? | memantine |
| which condition is a common side effect of valproate? | nausea, vomiting and indigestion |
| ethosuzimide is only indicated for which seizure type | absence |
| which statement describes the goal of pharmacologic therapy in the treatment of parkinson disease? | To balance cholinergic and dopaminergic activity in the brain |
| An elderly patient with Alzheimer's disease (AD) is prescribed donepezil. The patient's caretaker reports that there is no improvement in the patient's memory. What explanation should the nurse give for this lack of improvement? | Donepezil does not improve memory in some patients. |
| which statement describes the goal of pharmacologic therapy in the treatment of parkinson disease? | balance cholinergic and dopaminergic activities int he brain |
| which drug is used as an adunct therapy with levodopa/carbidopa to treat parkinson disease? | selegiline |
Created by:
alum91